Module 12: Osteoporosis (b) Flashcards Preview

6020 Pharmacology FINAL EXAM COMPLETE ☑️ > Module 12: Osteoporosis (b) > Flashcards

Flashcards in Module 12: Osteoporosis (b) Deck (19)
Loading flashcards...
1
Q

Osteoporosis

-Info

A
  1. Occurs most commonly in Postmenopausal women
    —Bone loss r/t estrogen deficiency and/or age
  2. Refer to Endocrinologist & Rheumatologist
2
Q

Causes of Accelerated Bone Loss?

A
  1. Chronic glucocorticoid use (>/= 5 mg prednisone for >/= 3 months
  2. (Depo-provera) — Max 2 yrs and encourage calcium and vitamin D — Eval BMD after 2 yrs of use
  3. Some Cancer drugs
  4. Excess thyroid hormone
  5. Other drugs that are implicated — TZDs, PPIs, anticonvulsants, SSRIs, and some SGLT2i, ART, look diuretics
3
Q

Med Class that minimizes Bone loss?

A
  1. Thiazide diuretics minimize bone los
4
Q

Bisphosphonates

A
  1. First Line treatment for osteoporosis in Postmenopausal women — Preferred initial therapy
  2. Inhibit bone resorption, slow down excessive bone loss, stabilize BMD and reduce fracture risk
  3. Example Meds: Alendronate (Fosamax) or Risedronate (Actonel) — Initial choice for oral bisphosphonate
    —May be taken daily or weekly — Some are monthly
  4. Check renal function**
5
Q

Bisphosphonates

-Patient Education

A
  1. Take on an empty stomach — First thing in the morning w/ 8 oz of plain water
  2. Must remain upright for 30 minutes (60 minutes w/ boniva) — During that time DO NOT eat or drink anything
  3. D/C if Sx’s of esophagitis develop — look for an option outside of an oral bisphosphonate
6
Q

IV Bisphosphonates

A
  1. Zoledronic Acid (Reclast) — Dosed YEARLY

2. A/E’s include RENAL effects — Monitor renal function

7
Q

Bisphosphonates

-A/E’s

A
  1. Hypocalcemia
  2. GI effects (oral) — Esophageal disease — D/C if this occurs
  3. Atypical femur fractures? — R/T longer duration of medication >5 years — D/C if this occurs
  4. Osteonecrosis of the jaw
    —Higher risk if pt has dental issues or poor oral hygiene — IV admin, CA therapy and glucocorticoids also contribute to A/Es
8
Q

Bisphosphonates

-Holidays?

A
  1. Consider holiday in 5 years if bone density is stable

2. Continue using medication for 10 years (oral) or 6 years (IV) if risk is still high

9
Q

Medications that Inhibit bone resorption

A
  1. Denosumab (Prolia)
  2. Raloxifene (Evista)
  3. Estrogen-Progestin — NOT recommended
10
Q

Anabolic Agents for Osteoporosis

A
  1. Teriparatide (Forteo)
  2. Abaloparatide (Tymlos)
  3. Romosozumab (Evenity)
11
Q

Denosumab (Prolia)

A
  1. RANK Ligand inhibitor
  2. Inhibits osteoclast formation, decreases bone resorption, increases bone mineral density
  3. SubQ injection q6 months
  4. Higher cost
  5. NOT usually an initial therapy for most Postmenopausal women

A/E’s

  • May cause Hypocalcemia — monitor calcium and check prior to initiating therapy
  • Osteonecrosis of the Jaw & atypical femur fractures

Treatment Length

  • Need INDEFINITE administration
  • Increased fracture risk when stopping medication
12
Q

Raloxifene (Evista)

-Estrogen Agonist/Antagonist

A
  1. Inhibits bone resorption
  2. Consider in women at high risk for breast cancer
  3. LESS effective than bisphosphonates and denosumab
    —Reduces risk of vertebral fractures — No demonstrated benefit for other fracture reduction
  4. BBW — Venous thromboembolism risk — FATAL stroke risk
    —Avoid w/ active/previous venous thromboembolism — Caution with CV risk
13
Q

Estrogen-Progestin Therapy

A
  1. NOT a first-line approach for Tx of osteoporosis — Increases risk of breast CA, CVA< venous thromboembolism, & coronary dz.
  2. May be considered in women w/ persistent menopausal Sx’s & failed on other Tx’s
14
Q

Anabolic Agents

-Examples

A
  1. Teriparatide or Abaloparatide
  2. Romosozumab
  3. Anabolic agents stimulate bone formation and activate bone remodeling
  4. LIMIT amount of time of therapy to 1-2 years MAX
15
Q

Anabolic Agents

-Teriparatide (Forteo) & Abaloparatide (Tymlos)

A
  1. Parathyroid hormone analog — Stimulates bone formation and activates bone remodeling
  2. SQ injection daily
  3. Most Expensive

A/Es
-Hypercalcemia/calciúria

  1. Only approved for MAX of 2 years
  2. BBW — osteosarcoma
16
Q

Anabolic Agents

-Teriparatide (Forteo) — Who can take it?

A
  1. Men or Postmenopausal women w/ severe osteoporosis
  2. Pt’s unable to tolerate bisphosphonates
  3. Pt’s who fail other osteoporosis therapies (Fx despite medications)
17
Q

Anabolic Agents

- Romosozumab

A
  1. Monoclonal anti-sclerostin antibody — newer anabolic agent for tax of osteoporosis in postmenopausal women at high risk for Fx
  2. NOT initial therapy — Severe cases
  3. A/Es — Serious CV events in a trial — AVOID in hx of MI or CVA
  4. Injected once monthly — Induces GREAT BMD response — LIMITED to 12 monthly doses*
18
Q

Osteoporosis treatment

-Combo treatment?

A
  1. Combination therapy NOT recommended at this time.
19
Q

Osteoporosis

-Calcium and Vitamin D

A
  1. Pt’s treated w/ Pharmacologic therapy for osteoporosis should have:
    - NORMAL serum calcium and vitamin D-25 (OH) levels prior to starting a therapy
  2. Calcium — 1200 mg/day
  3. Vitamin D — 800 IU daily